Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
PCMA warns HB 192 could raise costs and harm safety standards; committee questions impact
Summary
The Pharmaceutical Care Management Association testified that HB 192 would raise dispensing fees, risk a 'pill tax,' remove accreditation standards, and mandate reporting of acquisition costs in ways that could increase drug spending; committee members pressed PCMA on data and vertical integration trends.
Sean Stephenson, senior director of state affairs for the Pharmaceutical Care Management Association (PCMA), testified in opposition to House Bill 192, the Community Pharmacy Protection Act, arguing the bill contains provisions that would have unintended consequences for drug costs and patient safety.
Stephenson said HB 192 would, among other things, prohibit PBMs and plans from requiring third-party accreditation for pharmacies, impose…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
